TYRA - Tyra Biosciences, Inc.
9.13
-0.870 -9.529%
Share volume: 582,218
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$10.00
-0.87
-0.09%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-09-2024 | 08-07-2024 | 11-07-2024 | 03-27-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | |||
| Operating expenses | 22.322 M | 23.532 M | 28.604 M | 29.719 M | |
| Selling general and admin | 5.119 M | 5.535 M | 5.907 M | 7.539 M | |
| Research and development | 17.203 M | 17.997 M | 22.697 M | 22.180 M | |
| Total expenses | 22.322 M | 23.532 M | 28.604 M | 29.719 M | |
| 5.42% | 21.55% | 3.90% | |||
| Operating income | -22.322 M | -23.532 M | -28.604 M | -29.719 M | |
| Ebit | -22.322 M | -23.532 M | -28.604 M | -29.719 M | |
| Pretax income | -18.192 M | -18.702 M | -24.016 M | -25.571 M | |
| 2.80% | 28.41% | 6.47% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -18.192 M | -18.702 M | -24.016 M | -25.571 M | |
| -2.80% | -28.41% | -6.47% |
